Biosortia Pharmaceuticals

Ohio State and Biosortia Pharmaceuticals to Join Forces to Discover Anti-Cancer Compounds

The Ohio State University has signed an agreement with Biosortia Pharmaceuticals of Dublin, Ohio to discover new biologically active natural products with potential anti-cancer activity. Potential candidate compounds discovered during the Biosortia-sponsored research project will primarily be tested against human colon cancer assays. The ultimate goal is to obtain lead compounds that can be licensed to and developed by pharmaceutical companies through Biosortia’s pharmaceutical relationships. - February 28, 2013